H-1299

N/A

Report date: 2026/02/18 20:02:09

Base Information

Drug NameH-1299
Drug Alias NameH-1299
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungThoracic NeoplasmsEsophageal Neoplasms +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungThoracic NeoplasmsEsophageal Neoplasms +[7] 

Other Information

ATC CodeN/A
Related LinksN/A